Cargando…
Novel De Novo Mutation in Sulfonylurea Receptor 1 Presenting as Hyperinsulinism in Infancy Followed by Overt Diabetes in Early Adolescence
OBJECTIVE—Congenital hyperinsulinism, usually associated with severe neonatal hypoglycemia, may progress to diabetes, typically during the 4th decade of life in nonpancreatectomized patients. We aimed to genotype the ATP-sensitive K(+) channel in a 10.5-year-old girl presenting with overt diabetes f...
Autores principales: | Abdulhadi-Atwan, Maha, Bushmann, Jeremy, Tornovsky-Babaey, Sharona, Perry, Avital, Abu-Libdeh, Abdulsalam, Glaser, Benjamin, Shyng, Show-Ling, Zangen, David H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453628/ https://www.ncbi.nlm.nih.gov/pubmed/18390792 http://dx.doi.org/10.2337/db08-0159 |
Ejemplares similares
-
Relative Expression of a Dominant Mutated ABCC8 Allele Determines the Clinical Manifestation of Congenital Hyperinsulinism
por: Shemer, Ruth, et al.
Publicado: (2012) -
Diazoxide-Unresponsive Congenital Hyperinsulinism in Children With Dominant Mutations of the β-Cell Sulfonylurea Receptor SUR1
por: MacMullen, Courtney M., et al.
Publicado: (2011) -
GLP-1 Receptor Antagonist Exendin-(9-39) Elevates Fasting Blood Glucose Levels in Congenital Hyperinsulinism Owing to Inactivating Mutations in the ATP-Sensitive K(+) Channel
por: Calabria, Andrew C., et al.
Publicado: (2012) -
K(ATP) channel mutations in congenital hyperinsulinism: Progress and challenges towards mechanism-based therapies
por: ElSheikh, Assmaa, et al.
Publicado: (2023) -
TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH)
por: Srinivasan, Shylaja, et al.
Publicado: (2018)